4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-002385
Chief Scientific Officer sold 3,155 shares at $15.17 ($47,861)
- Chief Scientific Officer acquired 35,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…